Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1424.6023.85 (+1.7 %)
PREV CLOSE ( ) 1400.75
OPEN PRICE ( ) 1415.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6139
TODAY'S LOW / HIGH ( )1387.30 1442.95
52 WK LOW / HIGH ( )965.85 2004.05
NSE1430.6031.85 (+2.28 %)
PREV CLOSE( ) 1398.75
OPEN PRICE ( ) 1425.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1430.60 (33)
VOLUME 27632
TODAY'S LOW / HIGH( ) 1382.40 1448.95
52 WK LOW / HIGH ( )967 2002
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

02Feb Neuland Laboratories informs about ana
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
23Dec Neuland Laboratories informs about vot
In continuation to letter dated November 22, 2022, regarding the Postal..
13Dec Neuland Laboratories informs about iss
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Di..
24Nov Neuland Laboratories gets nod to trans
Neuland Laboratories has received approval to transfer company’s propert..
23Nov Neuland Laboratories informs about new
Pursuant to Regulation 47 of the Securities and Exchange Board of India..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit383.34635.340000000001
Gross Profit 530.62 817.400000000001
Operating Profit 694.091442.7
Net Sales 2937.069510.77

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  20867.55 (1.87%)
M.Cap ( in Cr)44342.09
Themis Medicare (BSE)
peergroup  1273.80 (4.48%)
M.Cap ( in Cr)1172.25
Piramal Enterprises (BSE)
peergroup  876.55 (3.42%)
M.Cap ( in Cr)20920.07
Hester Biosciences (BSE)
peergroup  1818.35 (1.30%)
M.Cap ( in Cr)1546.85
Sun Pharma Inds. (BSE)
peergroup  1027.65 (1.95%)
M.Cap ( in Cr)246567.66

Shareholding Pattern

NON-INSTITUTION 39.15%
PROMOTERS 36.14%
MUTUAL FUNDS/UTI 0.79%
GOVERNMENT 0.46%
FI/BANKS/INSURANCE 0%
FII 0%

Mf Holdings

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 1984. Its today's share price is 1424.6. Its current market capitalisation stands at Rs 1827.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 9510.77 Cr and Total Income of Rs.9531.53 Cr. The company's management includes Sarada Bhamidipati, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, Christopher M Cimarusti, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee HillsHyderabad-500033, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are KS Aiyar & Co, MSKA & Associates, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)